FMRFamide-related peptides potentiate transmission at the squid giant synapse. 1992

G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
Marine Biological Laboratories, Woods Hole, MA.

The stellate ganglion of the squid Loligo pealli contains the neuropeptides Phe-Met-Arg-Phe-NH2 (FMRFamide), Phe-Leu-Arg-Phe-NH2 (FLRFamide) and at least one N-terminally extended FMRFamide-related peptide that is yet to be fully characterized. Both local application and arterial perfusion of FLRFamide potentiate transmission at the giant synapse. The N-terminally related peptide Ser-Asp-Pro-Phe-Leu-Arg-Phe-NH2 (SDPFLRFamide) produced a similar effect. The threshold for both the tetra- and the hepta-peptides was less than 10 microM. Potentiation could be detected as an increase in rate of rise of the EPSPs, as an increase in amplitude of the EPSP in the absence of spikes, or under voltage clamp as an increase in the EPSC. The effect was most pronounced when the synapse was fatigued by high frequency stimulation. Another molluscan peptide, eledoisin and also leucine enkephalin were without effect. In the absence of any detectable effects of FLRFamide on the resting membrane potential of either pre- or postsynaptic terminals or on the presynaptic spike, it is suggested that the peptide influences transmitter mobilization. However, the peptide could also exert small changes in preterminal calcium currents, which so far we have been unable to detect.

UI MeSH Term Description Entries
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001158 Arteries The vessels carrying blood away from the heart. Artery
D013233 Stellate Ganglion A paravertebral sympathetic ganglion formed by the fusion of the inferior cervical and first thoracic ganglia. Cervicothoracic Ganglion,Cervicothoracic Ganglia,Stellate Ganglia,Ganglia, Cervicothoracic,Ganglia, Stellate,Ganglias, Stellate,Ganglion, Cervicothoracic,Ganglion, Stellate,Stellate Ganglias
D013569 Synapses Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions. Synapse
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
February 1975, The Journal of physiology,
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
October 2008, Proceedings of the National Academy of Sciences of the United States of America,
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
June 1976, Nature,
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
June 1992, Comparative biochemistry and physiology. Comparative physiology,
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
October 1969, Science (New York, N.Y.),
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
July 1978, Journal of neurobiology,
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
January 1969, Journal of neurobiology,
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
January 1967, The Journal of physiology,
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
July 1977, Neuroscience letters,
G A Cottrell, and J W Lin, and R Llinas, and D A Price, and M Sugimori, and E F Stanley
April 1982, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!